在儿童中对一般和严重的mycoplasma pneumoniae肺炎进行比较研究
Shuo Yang1, Sukun Lu2, Yinghui Guo3,4
1Institute of Pediatric Research, Children's Hospital of Hebei, 133 Jianhua South Street, Shijiazhuang, 050031, China.
BMC infectious diseases
|April 26, 2024
概括
在儿童中,严重的Mycoplasma pneumoniae肺炎 (SMPP) 与炎症增加和肺外问题有关. 有效的管理可能包括荷尔蒙疗法,抗凝剂和非巨型抗生素用于并发感染.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 呼吸系统医学 呼吸系统医学
背景情况:
- 严重的Mycoplasma pneumoniae肺炎 (SMPP) 在儿童群体中越来越令人担忧.
- 了解SMPP的特征和结果对于有效的治疗策略至关重要.
研究的目的:
- 描述SMPP儿童的特征,并评估他们的临床结果.
- 确定与儿科MPP严重疾病和并发症相关的因素.
主要方法:
- 在2022年1月至12月期间,对患有Mycoplasma pneumoniae肺炎 (MPP) 的住院儿童进行了回顾性分析.
- 收集的数据包括人口统计,临床特征,并发症,实验室结果和治疗结果.
- 疾病严重程度的分类是基于建立的儿科社区获得的肺炎指南.
主要成果:
- 分析了400多名患有MPP的儿童,其中50.6%被诊断为SMPP.
- 在SMPP病例中,潜在疾病,肺外并发症 (心肌,消化系统) 和细菌共同感染的比率更高.
- 患有SMPP的儿童表现出明显的炎症标志物,需要更积极的治疗,包括机械通风和非巨型抗生素.
结论:
- 患有SMPP的重病儿童表现出增强的炎症反应和更容易发生肺外并发症的倾向.
- 对于SMPP的治疗策略应该考虑激素治疗,抗凝固药和针对并发感染的向抗生素.
更多相关视频
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
9.1K
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
2.4K
相关概念视频
01:30Pneumonia III: Complications and Assessment
204
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
204
01:30Pneumonia I: Introduction
226
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
226
01:29Pneumonia II: Pathophysiology
261
The pathophysiology of pneumonia involves the following steps:
261
01:28Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323